LifeVantage (LFVN) Stock Price
LifeVantage Price
Revenue has compounded at 20.0% per year over the past 19 years to 228.53 M USD. Earnings per share have grown at 0.9% per year over the last 13 years. LifeVantage's net margin stands at 4.3%, down from 5.9% several years earlier. LifeVantage currently offers a dividend yield of about 2.62%. The payout ratio is around 23% of earnings. The dividend has grown at 24.8% per year over the past 3 years. Analysts set a median price target of 14.79 USD, implying 121.1% above the current price. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus. Over the past year LifeVantage shares have lost 48.9%. The stock trades about 66% above its 52-week low.
LifeVantage stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of LifeVantage over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how LifeVantage stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing LifeVantage's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | LifeVantage Price |
|---|---|
| 8/5/2026 | 6.69 USD |
| 8/4/2026 | 6.54 USD |
| 8/3/2026 | 6.58 USD |
| 7/31/2026 | 6.43 USD |
| 7/30/2026 | 6.29 USD |
| 7/29/2026 | 6.33 USD |
| 7/27/2026 | 6.26 USD |
| 7/23/2026 | 6.27 USD |
| 7/22/2026 | 6.35 USD |
| 7/21/2026 | 6.40 USD |
| 7/20/2026 | 6.26 USD |
| 7/17/2026 | 6.20 USD |
| 7/16/2026 | 6.18 USD |
| 7/15/2026 | 6.20 USD |
| 7/14/2026 | 6.20 USD |
| 7/13/2026 | 6.16 USD |
| 7/10/2026 | 6.24 USD |
| 7/9/2026 | 6.25 USD |
| 7/8/2026 | 6.18 USD |
| 7/7/2026 | 6.24 USD |
| 7/6/2026 | 6.18 USD |
| 7/2/2026 | 6.22 USD |
| 7/1/2026 | 6.25 USD |
| 6/30/2026 | 6.24 USD |
| 6/29/2026 | 6.20 USD |
| 6/26/2026 | 6.62 USD |
| 6/25/2026 | 6.65 USD |
| 6/24/2026 | 6.23 USD |
| 6/23/2026 | 6.18 USD |
| 6/22/2026 | 5.95 USD |
| 6/18/2026 | 6.41 USD |
| 6/17/2026 | 6.06 USD |
| 6/16/2026 | 6.04 USD |
| 6/15/2026 | 6.61 USD |
| 6/12/2026 | 9.05 USD |
| 6/11/2026 | 9.49 USD |
| 6/10/2026 | 9.48 USD |
| 6/9/2026 | 9.50 USD |
| 6/8/2026 | 10.70 USD |
| 6/5/2026 | 9.97 USD |
| 6/4/2026 | 9.31 USD |
| 6/3/2026 | 8.32 USD |
| 6/2/2026 | 8.62 USD |
| 6/1/2026 | 9.43 USD |
| 5/29/2026 | 7.87 USD |
| 5/28/2026 | 7.67 USD |
| 5/27/2026 | 8.05 USD |
| 5/26/2026 | 6.93 USD |
| 5/22/2026 | 5.61 USD |
| 5/21/2026 | 5.37 USD |
| 5/20/2026 | 5.25 USD |
| 5/19/2026 | 5.26 USD |
| 5/18/2026 | 5.19 USD |
| 5/15/2026 | 5.17 USD |
| 5/14/2026 | 5.12 USD |
| 5/13/2026 | 5.27 USD |
| 5/12/2026 | 5.15 USD |
| 5/11/2026 | 5.14 USD |
| 5/8/2026 | 5.34 USD |
| 5/7/2026 | 5.02 USD |
| 5/6/2026 | 6.00 USD |
| 5/5/2026 | 5.49 USD |
| 5/4/2026 | 5.13 USD |
| 5/1/2026 | 5.43 USD |
| 4/30/2026 | 5.05 USD |
| 4/29/2026 | 5.05 USD |
| 4/28/2026 | 5.19 USD |
| 4/27/2026 | 5.51 USD |
| 4/24/2026 | 5.08 USD |
| 4/23/2026 | 4.80 USD |
| 4/22/2026 | 4.90 USD |
| 4/21/2026 | 4.91 USD |
| 4/20/2026 | 5.13 USD |
| 4/17/2026 | 4.78 USD |
| 4/16/2026 | 4.57 USD |
| 4/15/2026 | 4.35 USD |
| 4/14/2026 | 4.14 USD |
| 4/13/2026 | 4.17 USD |
| 4/10/2026 | 4.15 USD |
| 4/9/2026 | 4.02 USD |
| 4/8/2026 | 4.07 USD |
| 4/7/2026 | 4.04 USD |
| 4/6/2026 | 4.18 USD |
| 4/2/2026 | 4.25 USD |
| 4/1/2026 | 4.20 USD |
| 3/31/2026 | 4.32 USD |
| 3/30/2026 | 4.40 USD |
| 3/27/2026 | 4.30 USD |
| 3/26/2026 | 4.29 USD |
| 3/25/2026 | 4.29 USD |
| 3/24/2026 | 4.33 USD |
| 3/23/2026 | 4.54 USD |
| 3/20/2026 | 4.67 USD |
| 3/19/2026 | 4.73 USD |
| 3/18/2026 | 4.65 USD |
| 3/17/2026 | 4.77 USD |
| 3/16/2026 | 5.15 USD |
| 3/13/2026 | 5.19 USD |
| 3/12/2026 | 5.15 USD |
| 3/11/2026 | 5.28 USD |
| 3/10/2026 | 5.20 USD |
| 3/9/2026 | 5.09 USD |
| 3/6/2026 | 4.88 USD |
| 3/5/2026 | 4.70 USD |
| 3/4/2026 | 4.91 USD |
| 3/3/2026 | 4.80 USD |
| 3/2/2026 | 4.52 USD |
| 2/27/2026 | 4.65 USD |
| 2/26/2026 | 4.68 USD |
| 2/25/2026 | 4.67 USD |
| 2/24/2026 | 4.53 USD |
| 2/23/2026 | 4.59 USD |
| 2/20/2026 | 4.85 USD |
| 2/19/2026 | 5.06 USD |
| 2/18/2026 | 4.93 USD |
| 2/17/2026 | 4.94 USD |
| 2/13/2026 | 5.03 USD |
| 2/12/2026 | 4.92 USD |
| 2/11/2026 | 5.09 USD |
| 2/10/2026 | 4.93 USD |
| 2/9/2026 | 5.07 USD |
| 2/6/2026 | 5.03 USD |
| 2/5/2026 | 4.62 USD |
| 2/4/2026 | 5.55 USD |
| 2/3/2026 | 5.36 USD |
| 2/2/2026 | 5.51 USD |
| 1/30/2026 | 5.30 USD |
| 1/29/2026 | 5.46 USD |
| 1/28/2026 | 5.79 USD |
| 1/27/2026 | 5.95 USD |
| 1/26/2026 | 5.86 USD |
| 1/23/2026 | 6.14 USD |
| 1/22/2026 | 5.97 USD |
| 1/21/2026 | 5.70 USD |
| 1/20/2026 | 6.01 USD |
| 1/16/2026 | 6.34 USD |
| 1/15/2026 | 6.33 USD |
| 1/14/2026 | 6.10 USD |
| 1/13/2026 | 6.20 USD |
| 1/12/2026 | 6.79 USD |
| 1/9/2026 | 6.49 USD |
| 1/8/2026 | 6.34 USD |
| 1/7/2026 | 6.24 USD |
| 1/6/2026 | 6.21 USD |
| 1/5/2026 | 6.09 USD |
| 1/2/2026 | 6.03 USD |
| 12/31/2025 | 6.16 USD |
| 12/30/2025 | 6.05 USD |
| 12/29/2025 | 6.25 USD |
| 12/26/2025 | 6.07 USD |
| 12/24/2025 | 6.33 USD |
| 12/23/2025 | 6.23 USD |
| 12/22/2025 | 5.99 USD |
| 12/19/2025 | 6.20 USD |
| 12/18/2025 | 6.26 USD |
| 12/17/2025 | 6.37 USD |
| 12/16/2025 | 6.33 USD |
| 12/15/2025 | 6.45 USD |
| 12/12/2025 | 6.50 USD |
| 12/11/2025 | 6.52 USD |
| 12/10/2025 | 6.65 USD |
| 12/9/2025 | 6.57 USD |
| 12/8/2025 | 6.61 USD |
| 12/5/2025 | 6.60 USD |
| 12/4/2025 | 6.97 USD |
| 12/3/2025 | 6.86 USD |
| 12/2/2025 | 6.48 USD |
| 12/1/2025 | 6.63 USD |
| 11/28/2025 | 6.87 USD |
| 11/26/2025 | 6.76 USD |
| 11/25/2025 | 6.77 USD |
| 11/24/2025 | 6.54 USD |
| 11/21/2025 | 6.43 USD |
| 11/20/2025 | 6.31 USD |
| 11/19/2025 | 6.40 USD |
| 11/18/2025 | 6.48 USD |
| 11/17/2025 | 6.29 USD |
| 11/14/2025 | 6.62 USD |
| 11/13/2025 | 6.47 USD |
| 11/12/2025 | 6.64 USD |
| 11/11/2025 | 6.58 USD |
| 11/10/2025 | 7.26 USD |
| 11/7/2025 | 7.40 USD |
| 11/6/2025 | 6.75 USD |
| 11/5/2025 | 7.31 USD |
| 11/4/2025 | 7.00 USD |
| 11/3/2025 | 7.34 USD |
| 10/31/2025 | 8.19 USD |
| 10/30/2025 | 8.07 USD |
| 10/29/2025 | 8.15 USD |
| 10/28/2025 | 8.51 USD |
| 10/27/2025 | 8.53 USD |
| 10/24/2025 | 8.67 USD |
| 10/23/2025 | 8.82 USD |
| 10/22/2025 | 8.67 USD |
| 10/21/2025 | 8.63 USD |
| 10/20/2025 | 8.54 USD |
| 10/17/2025 | 8.81 USD |
| 10/16/2025 | 8.97 USD |
| 10/15/2025 | 9.04 USD |
| 10/14/2025 | 9.04 USD |
| 10/13/2025 | 9.06 USD |
| 10/10/2025 | 8.96 USD |
| 10/9/2025 | 9.38 USD |
| 10/8/2025 | 9.20 USD |
| 10/7/2025 | 9.25 USD |
| 10/6/2025 | 9.51 USD |
| 10/3/2025 | 9.48 USD |
| 10/2/2025 | 9.57 USD |
| 10/1/2025 | 9.56 USD |
| 9/30/2025 | 9.73 USD |
| 9/29/2025 | 9.76 USD |
| 9/26/2025 | 10.19 USD |
| 9/25/2025 | 9.99 USD |
| 9/24/2025 | 10.28 USD |
| 9/23/2025 | 10.57 USD |
| 9/22/2025 | 10.55 USD |
| 9/19/2025 | 10.63 USD |
| 9/18/2025 | 10.90 USD |
| 9/17/2025 | 10.75 USD |
| 9/16/2025 | 10.71 USD |
| 9/15/2025 | 10.68 USD |
| 9/12/2025 | 11.13 USD |
| 9/11/2025 | 11.72 USD |
| 9/10/2025 | 11.23 USD |
| 9/9/2025 | 11.84 USD |
| 9/8/2025 | 11.44 USD |
| 9/5/2025 | 12.11 USD |
| 9/4/2025 | 13.46 USD |
| 9/3/2025 | 13.57 USD |
| 9/2/2025 | 13.55 USD |
| 8/29/2025 | 13.10 USD |
| 8/28/2025 | 13.10 USD |
| 8/27/2025 | 13.41 USD |
| 8/26/2025 | 12.93 USD |
| 8/25/2025 | 12.89 USD |
| 8/22/2025 | 13.08 USD |
| 8/21/2025 | 12.57 USD |
| 8/20/2025 | 12.40 USD |
| 8/19/2025 | 13.09 USD |
| 8/18/2025 | 13.69 USD |
| 8/15/2025 | 13.49 USD |
| 8/14/2025 | 13.68 USD |
| 8/13/2025 | 14.51 USD |
| 8/12/2025 | 14.16 USD |
| 8/11/2025 | 13.76 USD |
| 8/8/2025 | 13.30 USD |
| 8/7/2025 | 13.09 USD |
LifeVantage Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
LifeVantage Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.USD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 213.00 | 190.00 | 206.00 | 199.00 | 203.00 | 225.00 | 232.00 | 220.00 | 206.00 | 213.00 | 200.00 | 228.00 | 184.00 | 178.00 | 165.00 | 291.00 |
| 2.40 | -10.80 | 8.42 | -3.40 | 2.01 | 10.84 | 3.11 | -5.17 | -6.36 | 3.40 | -6.10 | 14.00 | -19.30 | -3.26 | -7.30 | 76.36 |
| 84.51 | 85.26 | 83.50 | 83.42 | 82.76 | 83.11 | 83.62 | 82.27 | 81.55 | 79.81 | 79.00 | 80.26 | 80.26 | 80.26 | 80.26 | 80.26 |
| 180.00 | 162.00 | 172.00 | 166.00 | 168.00 | 187.00 | 194.00 | 181.00 | 168.00 | 170.00 | 158.00 | 183.00 | 147.68 | 142.87 | 132.43 | 233.57 |
| 19.00 | 13.00 | 12.00 | 4.00 | 10.00 | 9.00 | 15.00 | 17.00 | 7.00 | 4.00 | 4.00 | 12.00 | 7.00 | 6.00 | 6.00 | 11.00 |
| 8.92 | 6.84 | 5.83 | 2.01 | 4.93 | 4.00 | 6.47 | 7.73 | 3.40 | 1.88 | 2.00 | 5.26 | 3.80 | 3.37 | 3.64 | 3.78 |
| 11.00 | 6.00 | 6.00 | 1.00 | 5.00 | 7.00 | 11.00 | 12.00 | 3.00 | 2.00 | 2.00 | 9.00 | 7.00 | 5.00 | 5.00 | 20.00 |
| 57.14 | -45.45 | – | -83.33 | 400.00 | 40.00 | 57.14 | 9.09 | -75.00 | -33.33 | – | 350.00 | -22.22 | -28.57 | – | 300.00 |
| – | – | – | – | – | – | – | – | 0.12 | 0.14 | 0.16 | 0.18 | 0.19 | 0.21 | 0.24 | – |
| – | – | – | – | – | – | – | – | – | 16.67 | 14.29 | 6.25 | 5.88 | 16.67 | 14.29 | – |
| 14.39 | 14.02 | 14.13 | 14.15 | 14.96 | 14.56 | 14.44 | 13.29 | 12.54 | 12.61 | 13.18 | 12.75 | 12.75 | 12.75 | 12.75 | 12.75 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales LifeVantage generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue LifeVantage retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare LifeVantage's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares LifeVantage has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against LifeVantage's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
LifeVantage stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
LifeVantage Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
LifeVantage business model & stock analysis
LifeVantage SWOT Analysis
Strengths
LifeVantage Corp has a strong product lineup consisting of scientifically-backed nutritional supplements and skincare products.
The company has built a solid reputation for using advanced biohacking techniques to improve overall health and wellness.
LifeVantage Corp has a robust network marketing distribution model, allowing for widespread product reach and efficient sales.
Weaknesses
LifeVantage Corp faces competition in the crowded health and wellness industry, which may make it challenging for the company to differentiate itself.
The dependence on network marketing may create a risk of overreliance on individual distributors, potentially affecting brand consistency and control.
The company's growth may be limited by regulatory restrictions in various markets, particularly related to health claims.
Opportunities
The increasing consumer trend towards preventive healthcare and wellness presents a significant opportunity for LifeVantage Corp to expand its market.
The expansion into international markets, particularly emerging economies with growing middle-class populations, could open up new revenue streams.
Collaboration with healthcare professionals and partnerships with research institutions can enhance the company's credibility and support the development of innovative products.
Threats
The health and wellness industry is subject to changing consumer preferences and trends, making it important for LifeVantage Corp to consistently adapt its product portfolio.
The potential emergence of new competitors with similar or even superior products may pose a threat to LifeVantage Corp's market position.
Stringent regulatory requirements, particularly related to product claims and marketing, can limit the company's ability to promote its products effectively.
LifeVantage Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
LifeVantage Segments
LifeVantage Revenue by Segment (1/3)
Max
Details
LifeVantage Revenue by Segment (2/3)
Max
Details
LifeVantage Revenue by Segment (3/3)
Max
Details
LifeVantage Revenue by Region
3 Years
5 Years
10 Years
Max
Details
LifeVantage Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
LifeVantage historical P/E ratio, EBIT multiple, and P/S ratio
LifeVantage annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
LifeVantage shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
LifeVantage stock splits
LifeVantage Dividend History
5 years of dividend payments · 3 consecutive increases
LifeVantage dividend history and estimates
Max
Details
LifeVantage dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current LifeVantage forecasts and price targets in August 2026
Analyst Price Targets 2026LifeVantage Analyst Rating Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| 5/7/2026 | Downgrade | BuyHold | |
| 2/18/2026 | Maintained | Buy | |
| 11/14/2025 | Maintained | Buy | |
| 2/12/2014 | Maintained | In Line |
LifeVantage Earnings Calls
LifeVantage Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 8/25/2026 | 0.13USD | - | 46.87 MUSD | - | 2026 Q4 |
| 5/4/2026 | 0.16USD | - | 48.72 MUSD | - | 2026 Q3 |
| 2/4/2026 | 0.15USD | - | 55.47 MUSD | - | 2026 Q2 |
| 11/7/2024 | 0.16USD | - | 50.62 MUSD | - | 2025 Q1 |
| 5/2/2024 | 0.17USD | - | 56.62 MUSD | - | 2024 Q3 |
| 1/31/2024 | 0.04USD | - | 55.74 MUSD | - | 2024 Q2 |
| 8/21/2023 | 0.20USD | - | 54.39 MUSD | - | 2023 Q4 |
| 5/1/2023 | 0.15USD | - | 52.87 MUSD | - | 2023 Q3 |
| 1/30/2023 | 0.05USD | - | 51.93 MUSD | - | 2023 Q2 |
| 11/2/2022 | 0.15USD | - | 51.03 MUSD | - | 2023 Q1 |
EESG©
Eulerpool ESG Scorecard© for the LifeVantage stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
LifeVantage shareholder structure
| % | Name |
|---|---|
15.89417% | |
6.88703% | |
5.76981% | |
5.09936% | |
4.34568% | |
4.17079% |
LifeVantage Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
8.20% | SEC ↗ | |
7.85% | SEC ↗ | |
7.85% | SEC ↗ | |
5.82% | SEC ↗ | |
5.80% | SEC ↗ | |
5.70% | SEC ↗ | |
5.38% | SEC ↗ | |
3.78% | SEC ↗ | |
1.90% | SEC ↗ | |
1.00% | SEC ↗ |
LifeVantage Executives and Management Board
15 members · avg. age 57 · 33 % women
Mr. Steven Fife (66)
President, Chief Executive Officer, Director · since 2017
2.82 M USD
Management
Mr. Todd Thompson (58)
Chief Information and Innovation Officer
Ms. Julie Boyster (40)
Chief Marketing Officer
Mr. Carl Aure (52)
Chief Financial Officer
Ms. Alissa Neufeld (46)
General Counsel, Corporate Secretary
Ms. Michelle Oborn-Virchow (45)
Chief People Officer
Ms. Kristen Cunningham (41)
Chief Sales Officer
Board of Directors
Mr. Raymond Greer (62)
Independent Chairman of the Board
Mr. Darwin Lewis (66)
Independent Director
Mr. Rajendran Anbalagan (49)
Independent Director
Mr. Dayton Judd (54)
Independent Director
Ms. Cynthia Latham (67)
Independent Director
Mr. Michael Beindorff (73)
Independent Director
LifeVantage Supply Chain
Frequently asked questions about LifeVantage
LifeVantage Corp is a company operating in the health and wellness industry. Its business model focuses on the development, manufacturing, and distribution of scientifically advanced nutritional supplements. LifeVantage Corp primarily offers products that aim to improve overall health and well-being, with a particular emphasis on cellular health. By leveraging scientific research and cutting-edge technologies, LifeVantage Corp strives to provide innovative solutions to individuals seeking to enhance their quality of life. Through its network marketing approach, the company also empowers independent distributors to share these products and earn income while promoting a healthier lifestyle.
LifeVantage Corp is primarily active in the health and wellness industry.
The main competitors of LifeVantage Corp in the market are Amway, Herbalife, Nu Skin Enterprises, and Usana Health Sciences.
LifeVantage Corp is a renowned health and wellness company established in 2003. Headquartered in Sandy, Utah, LifeVantage is dedicated to developing science-backed nutrigenomics products, aiming to redefine wellness and promote healthy living. With a mission to help individuals achieve their health goals, LifeVantage is committed to providing innovative nutritional supplements and skincare solutions that support overall well-being. As a leader in the direct-selling industry, LifeVantage has a global presence in North America, Europe, and the Asia-Pacific region. With its cutting-edge product line and focus on personalized health, LifeVantage Corp has become a trusted name in the wellness industry.
LifeVantage Corp has achieved several significant milestones in its journey. Firstly, the company successfully launched Protandim®, its flagship product, in 2005. This revolutionary dietary supplement gained immense popularity for its unique antioxidant properties. In 2008, LifeVantage Corp received widespread recognition when it was listed on the NASDAQ Stock Exchange. The company continued to expand its product portfolio and in 2016, introduced Axio®, a range of energy drinks. LifeVantage Corp's commitment to innovation and scientific research led to the development of NRF2 Synergizer™, a breakthrough formula in 2019. These achievements demonstrate LifeVantage Corp's continuous growth and dedication to providing high-quality wellness products to its consumers worldwide.
LifeVantage Corp primarily operates in countries and regions across the globe. The company has a significant presence in the United States, where it is headquartered. Additionally, LifeVantage Corp has established a strong foothold in Canada, Mexico, Japan, Australia, Hong Kong, and the Netherlands. With a wide-ranging international network, LifeVantage Corp continues to expand its footprint and reach customers in various markets.
LifeVantage Corp represents values and a corporate philosophy that emphasizes science-based solutions for better health and wellness. The company is committed to providing innovative products backed by extensive research and clinical studies. LifeVantage Corp is dedicated to empowering people to live healthier and happier lives through its leading-edge nutrigenomics technology. The company focuses on developing and distributing products that target oxidative stress, promote healthy aging, and support overall well-being. LifeVantage Corp's commitment to quality, integrity, and innovation drives its mission to help individuals achieve their health and financial goals. By combining cutting-edge science and a passion for transformative results, LifeVantage Corp is revolutionizing the way people approach their health and wellness.
Analysts currently set an average price target of 14.79 USD for the LifeVantage stock (median: 14.79 USD), implying +124.8 % versus the latest price. The consensus is based on 8 analyst ratings.
8 analysts currently rate the LifeVantage stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect LifeVantage to generate revenue of 184.20 M USD and earnings per share of 0.58 USD.
Converted at the current exchange rate, the LifeVantage share trades at 5.80 EUR (6.69 USD).
The LifeVantage share (LFVN) is listed on 2 stock exchanges, including: NASDAQ (LFVN), Frankfurt (L2T1.F).
The LifeVantage Corporation is a company that operates in the health and wellness market. It is considered a leading provider of nutritional supplements and skincare products. The company's business models are centered around direct selling and multi-level marketing (MLM), which means that independent distributors sell the products directly to end customers. The main products of LifeVantage are the nutritional supplements Protandim, Axio, and PhysIQ, as well as the skincare series TrueScience. All of these products are designed to improve the health and well-being of the user. Protandim is a nutritional supplement that has antioxidant and anti-inflammatory properties to support the immune system and cellular health. Axio is a drink-like nutritional supplement specifically designed to enhance mental clarity and energy. PhysIQ contains products that focus on healthy weight loss, metabolism, and digestive issues, while TrueScience skincare products provide antioxidant protection, anti-aging properties, and moisture to reduce damage from environmental factors or aging. According to the company, all products undergo comprehensive clinical studies to ensure effectiveness and safety, in order to provide customers with essential quality standards. The production of LifeVantage products takes place in excellent manufacturing facilities, and all ingredients are carefully reviewed. LifeVantage products are sold directly to independent distributors, who then sell these products to end customers. The multi-level marketing model of LifeVantage is aimed at supporting independent distributors. These distributors are able to build their own sales by selling products to customers and recruiting new distributors. Through this process, they can also earn commissions and increase their income by selling LifeVantage products and acquiring customers in their team. The LifeVantage Corporation also has a presence on social media platforms such as Facebook, Twitter, Instagram, and LinkedIn. Here, customers and prospects can be informed about current products and offers and establish connections with others in the LifeVantage community. They can also share their own experiences and make recommendations. Overall, the business model of LifeVantage is focused on direct sales and multi-level marketing. It provides independent distributors with the opportunity to build their own sales by selling products to customers and recruiting new distributors. Through this model, distributors can earn commissions and increase their income. LifeVantage products are tested for effectiveness and safety through clinical studies and are sold directly to distributors, who then resell them to end customers. The company's presence on social media and its focus on health and wellness-oriented products ensure that LifeVantage continues to be on a growth trajectory.
The expected revenue of LifeVantage is 184.20 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of LifeVantage is 7.45 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of LifeVantage is currently 11.45. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the LifeVantage stock.
The price-to-sales ratio (P/S) of LifeVantage is currently 0.46. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the LifeVantage stock.
The Eulerpool Quality Score for LifeVantage is 3/10.
The ISIN of LifeVantage is US53222K2050. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of LifeVantage is A1420J. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of LifeVantage is LFVN. The ticker symbol is used to trade LifeVantage shares on the stock exchange.
Over the past 12 months, LifeVantage paid a dividend of 0.18 USD . This corresponds to a dividend yield of about 2.62 %. For the coming 12 months, LifeVantage is expected to pay a dividend of 0.21 USD.
The current dividend yield of LifeVantage is 2.62 %.
LifeVantage pays a dividend, distributed in the months of , , , .
LifeVantage paid dividends every year for the past 4 years.
For the upcoming 12 months, dividends amounting to 0.21 USD are expected. This corresponds to a dividend yield of 3.15 %.
LifeVantage is assigned to the 'Non-cyclical consumption' sector.
To receive the latest dividend of LifeVantage from amounting to 0.05 USD, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
In the year 2025, LifeVantage distributed 0.15 USD as dividends.
The dividends of LifeVantage are distributed in USD.
LifeVantage stock
LifeVantage Peer Group
LifeVantage Ticker
LifeVantage FIGI
All fundamentals and in-depth analysis of LifeVantage
Our stock analysis for LifeVantage stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LifeVantage. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.